Our social responsibility strategy introduces new long-term ambitions to accelerate prevention to halt the rise of diabetes, provide access to affordable care for vulnerable patients in every country and to continue to drive innovation to improve lives.
?
We are expanding our Changing Diabetes??in Children programme to reach 100,000 children by 2030. Since the programme’s first child was enrolled in 2009, we have helped more than 25,000 children with type 1 diabetes get access to medical care and life-saving medicine in low-resource settings.?
Our Changing Diabetes? in Children programme
?
As part of our existing Access to Insulin Commitment, we are reducing
the ceiling price of human insulin from USD 4 to USD 3 per vial in 76
low- and middle-income countries.?This applies to?Least
Developed Countries as defined by the United Nations,? other
low-income countries as defined by the World Bank ?and
middle-income countries where large low-income populations lack
sufficient health coverage. We will also address challenges in
insulin distribution and healthcare capacity that often prevent
low-cost insulin from reaching the most vulnerable people.
Our access to insulin commitment
?
We are extending our partnership with the International Committee of
the Red Cross and the Danish Red Cross until 2023 and supporting with
a donation of DKK 15 million. Our Partnering for Change programme,
launched in 2018, will continue to provide help to the most vulnerable
patient groups during humanitarian crisis, including the integration
of diabetes and hypertension care into the Red Cross’s global health
operations.
Our work with Red Cross?partners
?
People with diabetes using Novo Nordisk insulin who have lost?health insurance coverage
because of a change in job status?due to COVID-19 may be eligible
for a free 90-day supply of?insulin through Novo Nordisk’s Diabetes
Patient Assistance?Program.
See
how we are supporting US patients
?
We are collaborating with leaders from over 25 cities to tackle?the rise of type 2 diabetes in urban environments.?
With nearly two-thirds of all people with diabetes living in?urban areas, cities are an important focal point for tackling the?problem.
Learn about our efforts to prevent type 2 diabetes in cities
?
We are donating and shipping free insulins to organisations?providing humanitarian
relief, such as UNICEF, UNRWA and our?Red Cross partners, for six
months.?The total value of the donation is?more than DKK 20
million.
Learn
more about our efforts in humanitarian crisis
?
Globally, 40 million children under the age of 5 are overweight putting many young people at risk of early onset of type 2 diabetes.
Together with UNICEF, we are working to help prevent childhood
overweight and obesity and help support actions that make a
difference.
See how we are working to prevent childhood obesity
?
As the number of people diagnosed with type 1 diabetes continues to rise, we are working to better understand what causes the disease - and how to prevent or cure it.
Our aim is to find new therapies that can delay, prevent and even cure type 1 diabetes.
?
Could digital health tools provide the solution to China’s burgeoning diabetes crisis? Our CEO Lars Fruergaard J?rgensen believes so.
?
Your risk of developing
type 2 diabetes is based on many factors - being middle aged or
older, being overweight, or having a family history of diabetes.?
Progression is gradual, so you may not even notice the symptoms
until they become obvious.
Take the type 2 diabetes risk test and help defeat diabetes
?
